The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligandsErika Tissino, Valter Gattei, Guido Capasso et al.|Leukemia|2024Cited by 6
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experienceRiccardo Bomben, Valter Gattei, Antonella Zucchetto et al.|HemaSphere|2024Cited by 1
Prevalence and Clinical Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Chronic Lymphocytic Leukemia and Richter TransformationChiara Cosentino, Riccardo Moia, Samir Mouhssine et al.|Blood|2024Cited by 1
CD49d Expression Is Included in a Revised 4-Factor Model Predicting Outcome in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Multi-Center Real-World ExperienceRiccardo Bomben, Valter Gattei, Antonella Zucchetto et al.|Blood|2023Cited by 0
CLL-1206: Prevalence and Clinical Impact of Clonal Hematopoiesis in Chronic Lymphocytic LeukemiaSamir Mouhssine, Riccardo Moia, Chiara Cosentino et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 0